Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis
1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural...
1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural...
1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in...
Pfizer and Innovent deepen the China biotech licensing wave Pfizer is making another large oncology bet, this time through a...
1. Incorporating procalcitonin-guided decision making in the management of neonatal late-onset sepsis significantly reduced the duration of antibiotic treatment without...
1. H3-10353, a novel γ-aminobutyric acid (GABA) positive allosteric modulator, is safe and well-tolerated in healthy patients and those with...
1. 1 litre polyethylene glycol with ascorbate (1L-PEG-Asc) showed superior bowel cleansing efficacy compared to 2 litre polyethylene glycol with...
1. Exposure to systemic glucocorticoid immunosuppression (gsISP) close to immune checkpoint inhibitor (ICI) initiation was associated with worse overall survival...
1. In adult patients with chronic low back pain (LBP) and disc herniation on magnetic resonance imaging (MRI), treatment with...
1. Delayed initiation of antibiotic therapy was strongly associated with treatment failure and prolonged hospitalization in hospitalized SSTI patients. 2....
1. Initiation of centrally acting analgesics in patients with osteoarthritis (OA) was associated with a higher long-term risk of total...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.